- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05706181
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
Home-based Heat Therapy to Improve Functional Capacity and Vascular Health in Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic whole-body heating (i.e., heat therapy) has gained attention as a novel strategy to improve clinical and physiological outcomes in a number of populations. However, whole-body heat therapy is quite uncomfortable and may require trained personnel to ensure participant safety, especially for those more at risk for heat-related illness. Moreover, the applicability and acceptability of whole-body heat therapy are questionable as equipment cost is substantial and adherence will be low if individuals are required to travel if they cannot afford in-home therapy. Home-based leg heat therapy offers an opportunity to leverage the demonstrated benefits of whole-body heat therapy while managing safety and convenience.
The hypothesis will be addressed in the following Specific Aims:
Aim 1: Determine the extent to which home-based leg heat therapy improves functional capacity in older adults. Functional capacity will be assessed before and after heat therapy or sham intervention via the 6-min walk test and the Short Physical Performance Battery.
Aim 2: Determine if home-based leg heat therapy improves vascular function and exercise hyperemia in the older adults of Aim 1. Using state-of-the-art techniques of skeletal muscle microdialysis and high-resolution duplex ultrasound, the investigators will pharmacodissect mechanisms of vascular function and exercise hyperemia before and after each intervention. The outcomes of Aim 2, while providing insight into the mechanisms whereby heat therapy improves functional capacity, should be considered independent of the outcomes of Aim 1 given that vascular health is a key independent, yet modifiable risk factor for cardiovascular morbidity and mortality.
Study Type
Enrollment (Estimated)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Contact
- Name: Steven A Romero, PhD
- Phone Number: 8177355159
- Email: steven.romero@unthsc.edu
Study Contact Backup
- Name: Amy Moore, RN
- Phone Number: 8177352088
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76107
- Recruiting
- University of North Texas Health Science Center
-
Contact:
- Steven A Romero, PhD
- Phone Number: 8177355159
- Email: steven.romero@unthsc.edu
-
Principal Investigator:
- Steven Romero, PhD
-
Sub-Investigator:
- Heidi Cope, BS
-
Contact:
- Heidi Cope, BS
- Phone Number: 817-735-2088
- Email: HeidiCope@my.unthsc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 55 to 80 years of age
- No tobacco/nicotine use within preceding 6 months (e.g., cigarettes, chewing tobacco, nicotine gum or patches, and vapor smoking)
- Systolic blood pressure <140 mmHg; diastolic blood pressure <90 mmHg
- Normal 12-lead ECG (reviewed by a physician)
- Normal clinical results from a medical exam reviewed by a board-certified physician (e.g., General Health Questionnaire - see attached document)
- Body mass index (BMI) <40 unless athletic/muscular build; calculation = body weight (kg)/height (m2)
- Females Only: Post-menopausal
Exclusion Criteria:
- Not meeting the age criteria
- Body mass index (BMI) >40 unless athletic/muscular build; calculation = body weight (kg)/height (m2)
- Use of tobacco or nicotine products within the last 6 months (tobacco cigarettes, chewing tobacco, nicotine patches or gum)
- Not abstaining from the following 24 hours prior to the experimental session: exercise, alcoholic substances, prescription or non-prescription medications (unless cleared by the medical screener), dietary supplements, herbal medications, caffeinated substances (including chocolate, coffee, tea (iced or hot), caffeinated energy drinks, and sodas)
- S who weigh less than 80 lbs
- Use of prescription drugs, non-prescription drugs or herbal medicines known to alter vascular function unless cleared prior to the study
- Use of anti-hypertensive medications
- Use of beta blockers
- Daily use of bronchodilators
- Current use of anti-coagulant therapy
- Current use of hormone replacement therapy (e.g., estrogen, testosterone)
- Current diagnosis of cancer
- Signs of overt cardio-metabolic abnormalities (e.g., uncontrolled diabetes - HbA1c >7.5, a resting systolic blood pressure >140mmHg or diastolic blood pressure >90mmHg; abnormal 12-lead ECG)
- History of cerebrovascular abnormalities (e.g., prior stroke, transient ischemic attacks, epilepsy, increased intracranial pressure)
- Known history of atherosclerosis (i.e., plaque formation)
- Autonomic dysfunction (e.g., Shy-Drager Syndrome, Bradbury-Eggleston syndrome, idiopathic orthostatic hypotension)
- Respiratory illnesses (e.g., chronic asthma (including exercise-induced asthma), Chronic Obstructive Pulmonary Disease, Reactive Airway Disease). Note: subjects with exercised-induced asthma or who have had COVID-19 will be allowed to participate
- History of anaphylaxis
- Severe phobia of needles
- History of alcohol or drug abuse which inhibits the participants ability to complete this study
- Latex allergy
- Known allergies or sensitivities to drugs used in the study (e.g., Lidocaine HCL, acetylcholine HCL, methacholine chloride, sodium nitroprusside, nitroglycerin, or related drugs)
- Implanted electronic medical devices (e.g. cardiac pacemaker)
- Tissue or skin abnormalities of the legs (e.g., infection, injury, open wound, ischemic tissue, phlebitis, active bleeding, neuropathy)
- Tissue or skin abnormalities of the arm (e.g., unhealed or open wound or circulatory deficits)
- Current Fever (oral temp >99.5 °F/ 37.5 °C) aa) Current use of PDE3 inhibitors (e.g., Viagra) or soluble guanylate cyclase (sGC) stimulators (e.g., riociguat), or unwillingness to withhold medication for 2 weeks prior to laboratory testing bb) Diagnosis of neurological disease or cognitive dysfunction cc) Cardiac surgery or cardiac events (e.g., coronary artery bypass graft surgery, myocardial infarction, heart failure) dd) Abnormal clotting, clots in deep veins in the legs or pelvis, or blood clots to the lungs ee) Individuals who have had mastectomies ff) History of methemoglobinemia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Home-based heat therapy and functional capacity in older adults
The investigators will determine the extent to which home-based leg heat therapy improves functional capacity in older adults.
Functional capacity will be assessed before and after heat therapy or sham intervention via the 6-min walk test and the Short Physical Performance Battery.
|
Participants will be required to perform 8 weeks of leg heat therapy using water-perfused pants 4 times per week, with each session lasting 60 min.
Skin temperature will be heated to about 40 °C.
The pants heating system (consisting of pants and a water circulator/heater) can finely and uniformly control these designated skin temperatures.
Participants will be randomly assigned to a group and provided with the pant heating system as well as a log book in which they are required to track the dates of each session.
Participants will also measure their blood pressure and heart rate prior to, during, and immediately after each heating session using a portable oscillometric device provided by our laboratory.
Participants will be required to perform 8 weeks of leg heat therapy using water-perfused pants 4 times per week, with each session lasting 60 min.
Skin temperature will be heated to about 40 °C.
The pants heating system (consisting of pants and a water circulator/heater) can finely and uniformly control these designated skin temperatures.
Participants will be randomly assigned to a group and provided with the pant heating system as well as a log book in which they are required to track the dates of each session.
Participants will also measure their blood pressure and heart rate prior to, during, and immediately after each heating session using a portable oscillometric device provided by our laboratory.
|
Experimental: Home-based heat therapy and vascular function and exercise hyperemia in older adults
The investigators will determine if home-based leg heat therapy improves vascular function and exercise hyperemia in the older adults of Aim 1.
Using state-of-the-art techniques of skeletal muscle microdialysis and high-resolution duplex ultrasound, the investigators will pharmacodissect mechanisms of vascular function and exercise hyperemia before and after each intervention.
The outcomes of Aim 2, while providing insight into the mechanisms whereby heat therapy improves functional capacity, should be considered independent of the outcomes of Aim 1 given that vascular health is a key independent, yet modifiable risk factor for cardiovascular morbidity and mortality.
|
Participants will be required to perform 8 weeks of leg heat therapy using water-perfused pants 4 times per week, with each session lasting 60 min.
Skin temperature will be heated to about 40 °C.
The pants heating system (consisting of pants and a water circulator/heater) can finely and uniformly control these designated skin temperatures.
Participants will be randomly assigned to a group and provided with the pant heating system as well as a log book in which they are required to track the dates of each session.
Participants will also measure their blood pressure and heart rate prior to, during, and immediately after each heating session using a portable oscillometric device provided by our laboratory.
Participants will be required to perform 8 weeks of leg heat therapy using water-perfused pants 4 times per week, with each session lasting 60 min.
Skin temperature will be heated to about 40 °C.
The pants heating system (consisting of pants and a water circulator/heater) can finely and uniformly control these designated skin temperatures.
Participants will be randomly assigned to a group and provided with the pant heating system as well as a log book in which they are required to track the dates of each session.
Participants will also measure their blood pressure and heart rate prior to, during, and immediately after each heating session using a portable oscillometric device provided by our laboratory.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 minute walk test
Time Frame: Before sham or heat therapy
|
The distance, in meters, covered while walking for 6 minutes will be used to assess functional capacity.
|
Before sham or heat therapy
|
6 minute walk test
Time Frame: After 8 weeks of heat therapy or sham
|
The distance, in meters, covered while walking for 6 minutes will be used to assess functional capacity.
|
After 8 weeks of heat therapy or sham
|
Macrovascular function
Time Frame: Before sham or heat therapy
|
High-resolution duplex ultrasound will be used to assess vasodilation following a 5 minutes of leg ischemia.
Vasodilation will calculated as the percent change in diameter of the superficial femoral that occurs following ischemia.
|
Before sham or heat therapy
|
Macrovascular function
Time Frame: After 8 weeks of heat therapy or sham
|
High-resolution duplex ultrasound will be used to assess vasodilation following a 5 minutes of leg ischemia.
Vasodilation will calculated as the percent change in diameter of the superficial femoral that occurs following ischemia.
|
After 8 weeks of heat therapy or sham
|
Blood flow response to exercise
Time Frame: Before sham or heat therapy
|
High-resolution duplex ultrasound will be used to assess the change in blood flow during graded plantar flexion exercise.
|
Before sham or heat therapy
|
Blood flow response to exercise
Time Frame: After 8 weeks of heat therapy or sham
|
High-resolution duplex ultrasound will be used to assess the change in blood flow during graded plantar flexion exercise.
|
After 8 weeks of heat therapy or sham
|
Microvascular function
Time Frame: Before sham or heat therapy
|
The microdialysis technique will be used to delivery small amounts of acetylcholine or methacholine and sodium nitroprusside to the skeletal muscle of the thigh.
Endothelial-dependent and endothelial-independent microvascular function can then be examined by assessing the increase in skeletal muscles blood flow during the infusion of acetylcholine/methacholine and sodium nitroprusside, respectively.
|
Before sham or heat therapy
|
Microvascular function
Time Frame: After 8 weeks of heat therapy or sham
|
The microdialysis technique will be used to delivery small amounts of acetylcholine or methacholine and sodium nitroprusside to the skeletal muscle of the thigh.
Endothelial-dependent and endothelial-independent microvascular function can then be examined by assessing the increase in skeletal muscles blood flow during the infusion of acetylcholine/methacholine and sodium nitroprusside, respectively.
|
After 8 weeks of heat therapy or sham
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical performance Battery
Time Frame: Before sham or heat therapy
|
Likert scale-based scores will be tabulated from a side-by-side stand test, semi-tandem stand test, and a tandem stand test.
|
Before sham or heat therapy
|
Physical performance Battery
Time Frame: After 8 weeks of heat therapy or sham
|
Likert scale-based scores will be tabulated from a side-by-side stand test, semi-tandem stand test, and a tandem stand test.
|
After 8 weeks of heat therapy or sham
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNorthTexas
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperemia
-
Laboratorios Sophia S.A de C.V.Completed
-
University of IowaCompletedBlood Pressure | Aging | Vasodilation | Active HyperemiaUnited States
-
Technical University of MunichMoving - ab jetzt gesund GmbHCompletedEndothelial Function (Reactive Hyperemia)Germany
-
National Research Centre for the Working Environment...Rigshospitalet, Denmark; University of Copenhagen; University Hospital Bispebjerg...RecruitingOxidative Stress | Heart Rate Variability | Heat Stress | Reactive Hyperemia | Micro RNA | DNA Strand BreaksDenmark
-
University of HelsinkiRecruitingDeep Caries | Pulpitis Reversible | Pulp HyperemiaFinland
-
University Hospital, GrenobleCompletedHealthy VolunteersFrance
-
Aligarh Muslim UniversityCompletedAnesthesia; Functional
-
Foundation for Maternal Infant and Lactation KnowledgeCompleted
-
Hospices Civils de LyonRecruitingVenous Congestion | Cardiovascular InsufficiencyFrance
-
M.D. Anderson Cancer CenterCompletedAbdominal Surgery | Thoracic SurgeryUnited States
Clinical Trials on Home-based leg heat therapy
-
Purdue UniversityAquilo SportsNot yet recruitingPeripheral Arterial Disease | Intermittent Claudication
-
Indiana UniversityPurdue UniversityNot yet recruitingHeart Failure With Preserved Ejection Fraction
-
University of Texas Southwestern Medical CenterRecruiting
-
Indiana UniversityNational Institute on Aging (NIA); Purdue UniversityRecruiting
-
Purdue UniversityIndiana Clinical and Translational Sciences Institute; American College of...Recruiting
-
University of British ColumbiaCanadian Lung AssociationRecruiting
-
Hacettepe UniversityCompletedPrimary Ciliary Dyskinesia | Kartagener Syndrome | Immotile Cilia SyndromeTurkey
-
Brigham Young UniversityRecruitingHigh Intensity Interval Training | Aging | Exercise Intolerance | Heat TherapyUnited States
-
Johns Hopkins UniversityAga Khan University; Aman FoundationCompletedHeat Illness | Heat | Heat Exposure | Heat Stroke | Heat Exhaustion | Heat Syncope, Sequela | Heat Collapse | Heat Stroke and SunstrokePakistan
-
University GhentTerminatedHypermobile Ehlers-Danlos Syndrome | Hypermobility Syndrome | Multidirectional Subluxation of ShoulderBelgium